Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients

Kidney International

Volumn 65, Issue 5, 2004, Pages 1826-1834

  Sester, Martina ^b   Sester, Urban ^b   Clauer, Peter ^b   Heine, Gunnar ^b   Mack, Ulrich ^b   Moll, Thomas ^b   Sybrecht, Gerhard W ^b   Lalvani, Ajit ^b   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

Flow cytometry; Hemodialysis; Immunodeficiency; Latent tuberculosis infection; T cell response; Tuberculin skin test

Indexed keywords

BCG VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; PROTEIN; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; AGED; BLOOD DONOR; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SKIN TEST; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 2342481136     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00586.x     Document Type: Conference Paper

References (46)

1. DYE C, SCHEELE S, DOLIN P, et al: Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686, 1999
2. U.S. RENAL DATA SYSTEM: 1999 Annual Data Report. Am J Kidney Dis 34:S9-S19, 1999
3. KÖHLER H, ARNOLD W, RENSCHIN G, et al: Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25:124-128, 1984
4. GIRNDT M, PIETSCH M, KÖHLER H: Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 26:454-460, 1995
5. SMIRNOFF M, PATT C, SECKLER B, et al: Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 113:25-27, 1998
6. WOELTJE KF, MATHEW A, ROTHSTEIN M, et al: Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 31:848-852, 1998
7. GIRNDT M, SESTER U, SESTER M, et al: Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 14:2807-2810, 1999
8. GIRNDT M, SESTER M, SESTER U, et al: Molecular aspects of T- and B-cell function in uremia. Kidney Int (Suppl 78):S206-211, 2001
9. MEUER SC, HAUER M, KURZ P, et al: Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 80:743-749, 1987
10. GIRNDT M, KÖHLER H, SCHIEDHELM-WEICK E, et al: T cell activation defect in hemodialysis patients: Evidence for a role of the B7/CD28 pathway. Kidney Int 44:359-365, 1993
11. GIRNDT M, SESTER M, SESTER U, et al: Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int 59:1382-1389, 2001
12. SESTER U, SESTER M, HAUK M, et al: T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 15:1217-1223, 2000
13. SCHINDLER R, LINNENWEBER S, SCHULZE M, et al: Gene expression of interleukin-1 beta during hemodialysis. Kidney Int 43:712-721, 1993
14. GIRNDT M, KÖHLER H, SCHIEDHELM-WEICK E, et al: Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47:559-565, 1995
15. GIRNDT M, SESTER U, KAUL H, et al: Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J Am Soc Nephrol 9:1689-1696, 1998
16. HUEBNER RE, SCHEIN MF, BASS JB, JR.: The tuberculin skin test. Clin Infect Dis 17:968-975, 1993
17. EUROPEAN BEST PRACTICE GUIDELINES FOR RENAL TRANSPLANTATION (Part 2). Nephrol Dial Transplant 17:39-43, 2002
18. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161:S221-247, 2000
19. LALVANI A, PATHAN AA, MCSHANE H, et al: Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163:824-828, 2001
20. SUNI MA, PICKER LJ, MAINO VC: Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 212:89-98, 1998
21. APPAY V, ROWLAND-JONES SL: The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. J Immunol Methods 268:9-19, 2002
22. SESTER M, SESTER U, GÄRTNER B, et al: Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 71:1287-1294, 2001
23. SESTER M, SESTER U, KÖHLER H, et al: Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection. Aids 14:2653-2660, 2000
24. SESTER M, SESTER U, ALARCON SALVADOR S, et al: Age-related decrease in adenovirus-specific T cell responses. J Infect Dis 185:1379-1387, 2002
25. LALVANI A, PATHAN AA, DURKAN H, et al: Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357:2017-2021, 2001
26. EWER K, DEEKS J, ALVAREZ L, et al: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.-1173, 2003
27. ANDERSEN P, MUNK ME, POLLOCK JM, et al: Specific immune-based diagnosis of tuberculosis. Lancet 356:1099-1104, 2000
28. WALDROP SL, DAVIS KA, MAINO VC, et al: Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J Immunol 161:5284-5295, 1998
29. ROSE DN: Benefits of screening for latent Mycobacterium tuberculosis infection. Arch Intern Med 160:1513-1521, 2000
30. PATHAN AA, WILKINSON KA, KLENERMAN P, et al: Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: Associations with clinical disease state and effect of treatment. J Immunol 167:5217-5225, 2001
31. BARRY SM, LIPMAN MC, BANNISTER B, et al: Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: A characteristic feature of active pulmonary and nonpulmonary tuberculosis. J Infect Dis 187:243-250, 2003
32. CHAPMAN AL, MUNKANTA M, WILKINSON KA, et al: Rapid detection of active and latent tuberculosis infection in HIV- positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. Aids 16:2285-2293, 2002
33. LEIN AD, VON REYN CF, RAVN P, et al: Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol 6:606-609, 1999
34. AREND SM, ANDERSEN P, VAN MEIJGAARDEN KE, et al: Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 181:1850-1854, 2000
35. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 44:19-34, 1995
36. APPAY V, PAPAGNO L, SPINA CA, et al: Dynamics of T cell responses in HIV infection. J Immunol 168:3660-3666, 2002
37. BORROW P, LEWICKI H, HAHN BH, et al: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103-6110, 1994
38. CALLAN MF, STEVEN N, KRAUSA P, et al: Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 2:906-911, 1996
39. CUCCHIARINI M, KAMMER AR, GRABSCHEID B, et al: Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol 203:111-123, 2000
40. GRUNER NH, GERLACH TJ, JUNG MC, et al: Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 181:1528-1536, 2000
41. APPAY V, DUNBAR PR, CALLAN M, et al: Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379-385, 2002
42. CHAMPAGNE P, OGG GS, KING AS, et al: Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-111, 2001
43. SALLUSTO F, LENIG D, FÖRSTER R, et al: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712, 1999
44. RENTENAAR RJ, GAMADIA LE, VAN DERHOEK N, et al: Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J Clin Invest 105:541-548, 2000
45. CONVERSE PJ, JONES SL, ASTEMBORSKI J, et al: Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: Effect of human immunodeficiency virus infection. J Infect Dis 176:144-150, 1997
46. MAZUREK GH, LOBUE PA, DALEY CL, et al: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286:1740-1747, 2001